T. Sfetsios

Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension.

G. Giannakoulas, G. Giannakoulas, L. Settas, 2008, Rheumatology.

follow-up : a male : female comparison Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year

L. Settas, T. Sfetsios, P. Boura, 2011 .

Clinical expression and morbidity of systemic lupus erythematosus during a post-diagnostic 5-year follow-up: a male:female comparison

L. Settas, L. Settas, T. Sfetsios, 2011, Lupus.

Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis

G. Giannakoulas, L. Settas, T. Dimitroulas, 2010, Clinical Rheumatology.

N-Terminal probrain natriuretic peptide as a biochemical marker in the evaluation of bosentan treatment in systemic-sclerosis-related pulmonary arterial hypertension

G. Giannakoulas, L. Settas, T. Dimitroulas, 2008, Clinical Rheumatology.

Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension.

G. Giannakoulas, T. Dimitroulas, T. Sfetsios, 2007, International Journal of Cardiology.

Significance of serum uric acid in pulmonary hypertension due to systemic sclerosis: a pilot study

G. Giannakoulas, L. Settas, T. Dimitroulas, 2011, Rheumatology International.

Clinical expression and course in patients with late onset systemic lupus erythematosus.

L. Settas, L. Settas, T. Sfetsios, 2013, Hippokratia.